FFA
IDYA icon

Farther Finance Advisors’s IDEAYA Biosciences IDYA Stock Holding History

Farther Finance Advisors’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$15.2K Sell
395
-5
-1% -$189 ﹤0.01% 4363
2026
Q2 		$14.8K Sell
400
-154
-28% -$4.71K ﹤0.01% 4174
2026
Q1 		$18K Sell
554
-365
-40% -$12.2K ﹤0.01% 3733
2025
Q4 		$31.8K Buy
919
+580
+171% +$18.5K ﹤0.01% 3114
2025
Q3 		$9.22K Buy
339
+251
+285% +$6.07K ﹤0.01% 3474
2025
Q2 		$1.85K Buy
88
+28
+47% +$537 ﹤0.01% 3725
2025
Q1 		$886 Buy
60
+35
+140% +$746 ﹤0.01% 3643
2024
Q4 		$643 Hold
25
– – ﹤0.01% 3384
2024
Q3 		$792 Buy
25
+4
+19% +$152 ﹤0.01% 3308
2024
Q2 		$754 Hold
21
– – ﹤0.01% 3163
2024
Q1 		$893 Hold
21
– – ﹤0.01% 2817
2023
Q4 		$747 Buy
21
+16
+320% +$478 ﹤0.01% 2841
2023
Q3 		$135 Buy
+5
New +$127 ﹤0.01% 2523

Other funds holding IDYA

CAM
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
TC
Trust Company Manhattan, Kansas $1.15B AUM 7.83% 1-Year Est. Return

Farther Finance Advisors's IDYA Position: Q3 2026 in Review

Farther Finance Advisors reduced its IDEAYA Biosciences (IDYA) stake by 1.3% in Q3 2026, selling an estimated $189 and leaving 395 shares worth $15.2K. The position accounts for ﹤0.01% of the portfolio, ranked #4363.

Farther Finance Advisors first reported a position in IDYA in Q3 2023 and has held it in 13 quarters since. The position peaked at $31.8K in Q4 2025. 7 funds tracked by Wall St. Rank hold IDYA as of Q3 2026.

  • Farther Finance Advisors held 395 shares of IDEAYA Biosciences worth $15.2K as of Q3 2026.
  • Farther Finance Advisors sold 5 IDEAYA Biosciences shares in Q3 2026, an estimated $189.
  • IDEAYA Biosciences made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #4363 holding.
  • Farther Finance Advisors first reported a position in IDEAYA Biosciences in Q3 2023 and has held it in 13 quarters since.
  • Farther Finance Advisors's IDEAYA Biosciences position peaked at $31.8K in Q4 2025.
  • 7 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.